0
Clinical Investigations in Critical Care |

Iron Lung vs Mask Ventilation in the Treatment of Acute on Chronic Respiratory Failure in COPD Patients*: A Multicenter Study

Antonio Corrado, MD, FCCP; Marco Confalonieri, MD; Santino Marchese, MD; Corrado Mollica, MD; Giuseppe Villella, MD; Massimo Gorini, MD; Rossana Della Porta, MD
Author and Funding Information

*From the Respiratory Intensive Care Unit (Drs. Corrado, Villella, and Gorini), Azienda Ospedaliera di Careggi Firenze, Florence, Italy; the Respiratory Intensive Care Unit (Drs. Confalonieri and Della Porta), Aziende Ospedaliere di Crema, Crema, Italy; and the Respiratory Intensive Care Unit (Dr. Mollica), Aziende Ospedaliere di Ospedale Forlanini Roma, Rome, Italy; and the Respiratory Intensive Care Unit (Dr. Marchese), Ospedale Civico, Palermo, Italy.

Correspondence to: A. Corrado, MD, FCCP, Unita’ di Terapia Intensiva Polmonare e, Fisiopatologia Toracica, Azienda Ospedaliera di Careggi, CTO, Largo Palagi 1, I-50136 Florence, Italy; e-mail: acorrado@qubisoft.it



Chest. 2002;121(1):189-195. doi:10.1378/chest.121.1.189
Text Size: A A A
Published online

Study objectives: Evaluation of the effectiveness of negative-pressure ventilation (NPV) with the use of the iron lung vs noninvasive positive-pressure ventilation (NIPPV) in the treatment of COPD patients with acute on chronic respiratory failure.

Design: A retrospective case-control study.

Setting: Four Italian respiratory intermediate ICUs.

Patients: Of a total of 393 COPD patients admitted to the ICU in 1996, 53 pairs were treated with the iron lung (NPV group). Patients treated with NIPPV (NIPPV group) were matched according to mean (± SD) age (70.3 ± 7.1 vs 70.3 ± 6.9 years, respectively), sex, causes of acute respiratory failure (ARF), APACHE (acute physiology and chronic health evaluation) II score (22.4 ± 5.3 vs 22.1 ± 4.6, respectively), pH (7.26 ± 0.05 vs 7.27 ± 0.04, respectively), and Paco2 (88.1 ± 11.5 vs 85.1 ± 13.5 mm Hg, respectively) on admission to the ICU. The effectiveness of matching was 98.4%.

Results: Five patients from the NPV group (9.4%) and seven patients from the NIPPV group (13.2%) needed endotracheal intubation (EI). The treatment failure rate (ie, death and/or need of EI) was 20.7% in the NPV group and 24.5% in the NIPPV group (difference was not significant). The mean duration of mechanical ventilation (29.6 ± 28.6 vs 62.3 ± 35.7 h, respectively) and length of hospital stay (10.4 ± 4.3 vs 15 ± 5.2 d, respectively) among the 35 concordant surviving pairs were significantly lower in the NPV group than in the NIPPV group (p = 0.001 and p = 0.001, respectively).

Conclusions: These data suggest that both ventilatory techniques are equally effective in avoiding EI and death in COPD patients with ARF. Prospective trials are needed to confirm these preliminary results.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543